1 Case Selection Criteria 1.Age: 21 to 88 years old. 2.Sex: both males and females. 3. All patients were diagnosed with primary OSCC by a pathological examination. Patients were excluded if they had a history of systemic chemotherapy or radiotherapy, concomitant malignancy, active inflammatory bowel disease, active gastric/duodenal ulcer, active infection, severe heart disease, mental disorder, or other severe concurrent disease. Pregnant or lactating women were also excluded;
4. The local range of the tumor invasion was too large to cure radically by simple surgery or there was a large wound that could not be repaired and affected the functional reconstruction after surgery; 5. Distant metastasis in imaging examinations was not found in all of the patients; 6. There were no treatment-related contraindications; and 7. Before treatment, patients had an Eastern Cooperative Oncology Group performance status of 0 or 1, a life expectancy ≥3 months, and adequate organ functions (leukocytes 4,000/mm3, platelets ≥100,000/mm3, hemoglobin ≥9.0 g/dl, aspartate aminotransferase (AST) ≤2 times the upper normal limit (UNL), alanine aminotransferase (ALT) ≤2 times the UNL, alkaline phosphatase (ALP) ≤2 times the UNL, serum bilirubin ≤1.5 mg/dl, and serum creatinine ≤UNL).
All study protocols were approved by the Fuzhou General Hospital institutional review board at each participating center. All patients provided written informed consent before entry into this study.
Exclusion criteria
• Previous radiotherapy or chemotherapy.
• Can not tolerate the treatment protocol with systematic diseases such as history of severe pulmonary or cardiac diseases.
• Pregnancy (confirmed by serum or urine β-HCG) or lactation period. Legal incapacity or limited legal capacity.
•Other previous malignancies within 5 years.
•Evidence of distant metastatic disease and other cancers. 7 Kaplan-Meier analysis of the local recurrence rate www.impactjournals.com/oncotarget Distant metastasis rate was also uncommon. The 5-year local recurrence rate was 2.88% (3/104). At the 12, 24, and 48 month timepoints, no distant metastases had occurred during follow-up.
Kaplan-Meier analysis of restriction of mouth opening
The 5-year restriction of mouth opening was 2.88% (3/104). At the 6, 24, and 36 month timepoints, no restrictions of mouth opening during follow-up had occurred.
The 5-year postoperative survival rate was 91.35% (95/104). At the 12, 36, and 48 month timepoints, 5 cases had succumbed during follow-up. After the follow-up of the 104 cases of patients, four cases were lost, and these four were counted as deaths.
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